Tolerability of new antiepileptic drugs: a network meta-analysis
- 4 April 2017
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 73 (7) , 811-817
Abstract
The objective of this study was to perform a comparative assessment of tolerability of all licensed new antiepileptic drugs (AEDs) through a network meta-analysis (NMA) including all placebo-controlled double-blind clinical trials (RCTs) in all conditions in which these drugs have been tested.Keywords
This publication has 28 references indexed in Scilit:
- Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: Reply to Costa et al.Epilepsia, 2011
- Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta-analysisEpilepsia, 2011
- The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trialsEpilepsia, 2011
- Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta‐analysisEpilepsia, 2011
- A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic DrugsCNS Drugs, 2010
- Placebo responses in randomized trials of antiepileptic drugsEpilepsy & Behavior, 2010
- Neurological comorbidity and epilepsy: implications for treatmentActa Neurologica Scandinavica, 2009
- The role of titration schedule of topiramate for the development of depression in patients with epilepsyEpilepsia, 2009
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002